Telomerase inhibition, telomerase shortening, and senescence of cancer cells by tea catechins

被引:203
|
作者
Naasani, I
Seimiya, H
Tsuruo, T
机构
[1] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Toshima Ku, Tokyo 1708455, Japan
[2] Univ Tokyo, Inst mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan
基金
日本科学技术振兴机构;
关键词
D O I
10.1006/bbrc.1998.9075
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Animal in vivo studies and human epidemiological observations indicated potent anticancer effects for tea. Here we demonstrate that epigallocatechin gallate (EGCG), a major tea catechin, strongly and directly inhibits telomerase, an enzyme essential for unlocking the proliferative capacity of cancer cells by maintaining the tips of their chromosomes. Telomerase inhibition was elaborated in a cell-free system (cell extract) as well as in living cells. In addition, the continued growth of two representative human cancer cell lines, U937 monoblastoid leukemia cells and HT29 colon adenocarcinoma cells, in the presence of nontoxic concentrations of EGCG showed life span limitations accompanied with telomere shortening, chromosomal abnormalities, and expression of the senescence-associated beta-galactosidase. It is suggested that telomerase inhibition could be one of the major mechanisms underlying the anticancer effects of tea. (C) 1998 Academic Press.
引用
收藏
页码:391 / 396
页数:6
相关论文
共 50 条
  • [31] Inhibition of telomerase in canine cancer cells following telomestatin treatment
    Long, S.
    Argyle, D. J.
    Gault, E. A.
    Nasir, L.
    VETERINARY AND COMPARATIVE ONCOLOGY, 2007, 5 (02) : 99 - 107
  • [32] Inhibition of telomerase activity in human cancer cells by RNA interference
    Kosciolek, BA
    Kalantidis, K
    Tabler, M
    Rowley, PT
    MOLECULAR CANCER THERAPEUTICS, 2003, 2 (03) : 209 - 216
  • [33] Consequences of telomerase inhibition and combination treatments for the proliferation of cancer cells
    Chen, Z
    Koeneman, KS
    Corey, DR
    CANCER RESEARCH, 2003, 63 (18) : 5917 - 5925
  • [34] For better or worse? Telomerase inhibition and cancer
    de Lange, T
    Jacks, T
    CELL, 1999, 98 (03) : 273 - 275
  • [35] Telomerase Inhibition, Telomere Shortening, and Cellular Uptake of the Perylene Derivatives PM2 and PIPER in Prostate Cancer Cells
    Kaewtunjai, Navakoon
    Summart, Ratasark
    Wongnoppavich, Ariyaphong
    Lojanapiwat, Bannakij
    Lee, T. Randall
    Tuntiwechapikul, Wirote
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2019, 42 (06) : 906 - 914
  • [36] Telomerase and cancer stem cells
    Armanios, M.
    Greider, C. W.
    Molecular Approaches to Controlling Cancer, 2005, 70 : 205 - 208
  • [37] Role of telomeres and telomerase in genomic instability, senescence and cancer
    Deng, Yibin
    Chang, Sandy
    LABORATORY INVESTIGATION, 2007, 87 (11) : 1071 - 1076
  • [38] Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death
    Herbert, BS
    Pitts, AE
    Baker, SI
    Hamilton, SE
    Wright, WE
    Shay, JW
    Corey, DR
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (25) : 14276 - 14281
  • [39] Telomere dynamics and telomerase activity in cell senescence and cancer
    Bacchetti, S
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 1996, 7 (01) : 31 - 39
  • [40] Resistance to senescence induction and telomere shortening by a G-quadruplex ligand inhibitor of telomerase
    Gomez, D
    Aouali, N
    Renaud, A
    Douarre, C
    Shin-ya, K
    Tazi, J
    Martinez, S
    Trentesaux, C
    Morjani, H
    Riou, JF
    CANCER RESEARCH, 2003, 63 (19) : 6149 - 6153